Buccal delivery system for proteinaceous medicaments
CA 2361262 A1 · Owner: Esperanza Peptide, Ltd. · Inventors: Mundschenk, David D.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A delivery formulation and system for delivering proteinaceous medicaments such as inactivated bioactive peptides to the body. The formulation includes effective amounts of the peptide as well as a tissue (e.g. mucosal) permeation enchancer selected from the group consisting of quaternary ammonium salts. The system can be used, for instance by spraying the formulation into , the buccal cavity e.g. to the roof of the mouth.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 28, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended January 28, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 28, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.